• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Greene calls for yanking FDA approval of COVID-19 vaccines: ‘Causing permanent harm and deaths’

by March 21, 2025
written by March 21, 2025

Rep. Marjorie Taylor Greene, R-Ga., declared that U.S. Food and Drug Administration approval for COVID-19 vaccines should be yanked, asserting that the jabs ‘are causing permanent harm and deaths.’

‘FDA approval for COVID-19 vaccines needs to be pulled and they need taken off the childhood vaccine schedule ASAP,’ she said Thursday in a post on X. ‘I’ve been saying this ever since they were created and my personal Twitter account was permanently banned for my outspoken stance against the vaccines until Elon Musk bought Twitter, changed it to X, and restored my account along with thousands of people who were censored and silenced.’

The child and adolescent immunization schedule on the Centers for Disease Control and Prevention website includes COVID-19 vaccine recommendations for children 6 months old and above.

Greene contends that the jabs should never have been approved in the first place.

‘COVID-19 vaccines should have never received approval and they’ve known the entire time how bad the side effects are and deaths caused by them. It’s time to do the right thing. Stop the COVID-19 vaccines,’ she declared in her post.

But the CDC notes, ‘COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. There is currently no FDA-approved or FDA-authorized COVID-19 vaccine for children younger than age 6 months. CDC recommends that people stay up to date with COVID-19 vaccination.’

‘Cases of myocarditis and pericarditis have rarely been observed following receipt of COVID-19 vaccines used in the United States,’ the CDC indicates.

‘Evidence from multiple monitoring systems support a causal association for mRNA COVID-19 vaccines (Moderna or Pfizer-BioNTech) and myocarditis and pericarditis. Cases have occurred most frequently in adolescent and young adult males within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Moderna and Pfizer-BioNTech); however, cases have also been observed in females and after other doses.’

Rep. Thomas Massie has also expressed the view that the FDA should nix approval for the COVID-19 vaccines. 

‘FDA should immediately revoke approval of these shots,’ he tweeted last month.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump warns of jail time for Tesla vandals, anyone funding the attacks: ‘WE ARE LOOKING FOR YOU!!!’
next post
Trump’s hostage envoy Boehler met with Taliban in Kabul in first in-person meeting since takeover

related articles

Inside longtime Biden aide’s marathon closed-door grilling in...

July 12, 2025

David Gergen, trusted White House advisor to 4...

July 11, 2025

Who is Ashley Williams, the longtime Biden aide...

July 11, 2025

Jasmine Crockett rips Trump ‘regime,’ vows ‘solidarity’ with...

July 11, 2025

JONATHAN TURLEY: Justice Jackson plays pundit to dismay...

July 11, 2025

‘Nothing to stand on’: Ex-White House physician slams...

July 11, 2025

State Department to axe 1,800 employees

July 11, 2025

Biden cover-up probe heats up as another ex-White...

July 11, 2025

State Department to begin mass layoffs of about...

July 11, 2025

Duffy just got an additional job in Trump’s...

July 11, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Kim Jong Un shows off his nuclear facility and calls for ‘exponential’ increase in warheads

    September 13, 2024
  • ‘It’s a mess’: Vulnerable House Dem shreds Biden on border crisis in ‘closing message’ of campaign

    October 22, 2024
  • DOGE slashes billions more in expenses for programs like Peruvian climate change and gender equity in Mexico

    March 27, 2025
  • Ocado Share Price and It’s Financial Overview

    August 9, 2024
  • KraneShares launches AGIX ETF amid market volatility, betting on robust demand for AI technologies

    July 19, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,319)
  • Investing (634)
  • Stock (841)

Latest Posts

  • Project 2025 remains nonpartisan, true to 1980s good-gov’t inception despite raucous outcry, key figures say

    September 3, 2024
  • Pope Francis-era deal with Chinese Communist Party again under scrutiny as Pope Leo takes the reins

    May 9, 2025
  • Heritage chief mum on House Dems’ demand for a meeting as left digs in on Project 2025

    August 8, 2024

Recent Posts

  • Trump calls for judge in deportation legal battle to be impeached

    March 18, 2025
  • 2024 showdown: New polls this weekend in three key battlegrounds in Harris-Trump White House race

    August 11, 2024
  • National security experts warn against ‘chaos’ of US elections as Harris enters race

    July 23, 2024

Editor’s Pick

  • S&P 500 climbs for best day since early June as Nvidia shares lead tech turnaround

    July 23, 2024
  • Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

    April 15, 2025
  • Independents RFK Jr., Tulsi Gabbard to spin for Trump at debate, joining Vance and other Republicans

    September 10, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock